Immunoglobulin heavy chain and T-cell receptor beta chain gene rearrangements in acute non lymphoid leukemia. 1990

R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
Dipartimento di Biopatologia Umana, Università La Sapienza, Roma, Italy.

The occurrence of immunoglobulin heavy chain (IgH) and/or T-cell receptor (TcR) gene rearrangements has been reported in some cases of acute non lymphoid leukemia (ANLL), and variously interpreted as reflecting "aberrant gene expression" or "lineage promiscuity" of the leukemic cell. In an attempt to verify the incidence, FAB distribution and immunophenotypic correlates of gene rearrangements in ANLL, we analyzed the configuration of IgH and TcR beta chain genes in 70 patients with ANLL. In all cases myeloid (CD13, CD33, CD14, CD15) and lymphoid (CD7, CD2, CD10, CD19, TdT) antigenic determinants were analyzed in conjunction with conventional morpho-cytochemical characterization. Clonal rearrangements of the IgH gene were identified in 6/70 ANLL patients (8.6%), whereas in only 2/48 (4.2%) were T beta rearrangements documented. Concerning FAB subtypes, IgH or T beta rearrangements were detected in the less differentiated forms MO and M1 (3 cases), as well as in 2 M4 and 1 M5a cases. With the exception of a higher incidence of gene rearrangements in TdT+ ANLL, no significant correlation was found with other immunophenotypic markers.

UI MeSH Term Description Entries
D007143 Immunoglobulin Heavy Chains The largest of polypeptide chains comprising immunoglobulins. They contain 450 to 600 amino acid residues per chain, and have molecular weights of 51-72 kDa. Immunoglobulins, Heavy-Chain,Heavy-Chain Immunoglobulins,Ig Heavy Chains,Immunoglobulin Heavy Chain,Immunoglobulin Heavy Chain Subgroup VH-I,Immunoglobulin Heavy Chain Subgroup VH-III,Heavy Chain Immunoglobulins,Heavy Chain, Immunoglobulin,Heavy Chains, Ig,Heavy Chains, Immunoglobulin,Immunoglobulin Heavy Chain Subgroup VH I,Immunoglobulin Heavy Chain Subgroup VH III,Immunoglobulins, Heavy Chain
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015321 Gene Rearrangement The ordered rearrangement of gene regions by DNA recombination such as that which occurs normally during development. DNA Rearrangement,DNA Rearrangements,Gene Rearrangements,Rearrangement, DNA,Rearrangement, Gene,Rearrangements, DNA,Rearrangements, Gene
D015333 Gene Rearrangement, beta-Chain T-Cell Antigen Receptor Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors. T-Cell Antigen Receptor beta-Chain Gene Rearrangement,T-Lymphocyte Antigen Receptor beta-Chain Gene Rearrangement,Gene Rearrangement, beta-Chain T Cell Antigen Receptor,T Cell beta-Chain Gene Rearrangement,T Lymphocyte beta-Chain Gene Rearrangement,Gene Rearrangement, beta Chain T Cell Antigen Receptor,T Cell Antigen Receptor beta Chain Gene Rearrangement,T Cell beta Chain Gene Rearrangement,T Lymphocyte Antigen Receptor beta Chain Gene Rearrangement,T Lymphocyte beta Chain Gene Rearrangement

Related Publications

R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
February 1987, Molecular biology & medicine,
R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
September 1986, Journal of immunology (Baltimore, Md. : 1950),
R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
February 1986, The Journal of experimental medicine,
R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
July 1985, Lancet (London, England),
R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
May 2000, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
February 1994, European journal of clinical investigation,
R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
January 1990, Haematology and blood transfusion,
R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
September 2013, World journal of gastroenterology,
R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
August 1988, Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
R Leone, and F Lo Coco, and G De Rossi, and D Diverio, and M Frontani, and A Spadea, and A M Testi, and I Cordone, and F Mandelli
January 1991, Leukemia research,
Copied contents to your clipboard!